# Bevacizumab dosing strategy in paediatric cancer patients based on population pharmacokinetic analysis with external validation

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/bevacizumab-dosing-strategy-in-paediatric-cancer-patients-based-on-population/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Kelong Han,Thomas Peyret,Angelica Quartino,Nathalie Gosselin,Sridharan Gururangan,Michela Casanova,Johannes H. M. Merks,Maura Massimino,Jacques Grill,Najat C. Daw,Fariba Navid,Jin Jin,David E. Allison |
| Citations | 43 |
| DOI | 10.1111/bcp.12778 |
| Fields | Medicine |
| Open Access | true |
| OA Status | hybrid |
| OA URL | https://bpspubs.onlinelibrary.wiley.com/doi/pdfdirect/10.1111/bcp.12778 |
| OpenAlex ID | https://openalex.org/W2109706112 |
| PMID | 26345283 |
| Type | article |
| Year | 2015 |

## Paper authors

- [Thomas Peyret](https://scholariq.org/researchers/thomas-peyret/)

## Paper primary topic

- [Acute Lymphoblastic Leukemia research](https://scholariq.org/topics/acute-lymphoblastic-leukemia-research/)

## Paper topics

- [Acute Lymphoblastic Leukemia research](https://scholariq.org/topics/acute-lymphoblastic-leukemia-research/)
- [Pharmaceutical studies and practices](https://scholariq.org/topics/pharmaceutical-studies-and-practices/)
- [Cancer Treatment and Pharmacology](https://scholariq.org/topics/cancer-treatment-and-pharmacology/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.